Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563)

Transplant Proc. 1994 Dec;26(6):3114-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Bone Marrow Transplantation / immunology*
  • Drug Resistance
  • Female
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / therapy*
  • Humans
  • Immunosuppression Therapy* / adverse effects
  • Male
  • Middle Aged
  • Receptors, Interleukin-2 / immunology*
  • Recurrence
  • Survival Rate
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Receptors, Interleukin-2
  • inolimomab